# Amgen breaks ground on next-generation biomanufacturing plant in Rhode Island

Amgen broke ground on a new next-generation biomanufacturing plant at its West Greenwich, Rhode Island campus. The company expects to invest up to $200 million in the 120,000 square foot facility, which will use innovative technologies to produce medicines for U.S. and global markets.

- Type: New facility
- Announced: 2018-07-31
- Where: West Greenwich, Rhode Island, United States
- Value: $200.0M
- Status: under construction
- Capacity: 120,000 square feet
- Products: biologic medicines
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Amgen](https://endata.com/companies/21121.md)

## Sources

- [amgen.com](https://www.amgen.com/newsroom/press-releases/2018/07/amgen-breaks-ground-on-next-generation-biomanufacturing-plant-in-rhode-island), 2018-07-31: "We are working to extend that advantage even further with a next-generation biomanufacturing plant in Rhode Island that will produce medicines to serve patients around the world."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.